Notice of Effectiveness (effect)
April 20 2022 - 6:06AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | April 19,
2022 |
---|
Accession Number: | 0001213900-22-019866 |
---|
Submission Type: | POS AM |
---|
CIK: | 0001601936 |
---|
Company Name: | Altamira Therapeutics Ltd. |
---|
File Number: | 333-262592 |
---|
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Apr 2024 to May 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From May 2023 to May 2024